- Are we on a way to universal CDISC adoption? - case studies by Novartis, Baxter and Boehringer Ingelheim
- What are the requirements for GCP-compliant data management in multinational clincial trials? - presented by ECRIN
- How to choose a successful outsourcing model? - case studies by Sanofi, Servier and LEO Pharma
- Will data managers cease to exist? - discussed by European and American Vice Presidents and Global Heads of Roche, Abbott, Astellas and Eli Lilly
All this and much more will be presented by executive level experts of the Pharma industry, University hospitals and Clinical trials centres – Frank Shen (VP, Abbott Global Pharmaceutical R&D), Pantaleo Nacci (Global Head, Novartis Vaccines and Diagnostics), Susanne Gronen (VP, Astellas Pharma US) and many others.
Get more info here: http://pharma.flemingeurope.com/pharmacovigilance-risk-strategies/program/